Genoscience Pharma was initially dedicated to the development of antiviral compounds against Hepatitis C virus. Several protease inhibitors were developed, leading to the discovery of a new chemical entity family inhibiting autophagy, and efficient against Hepatitis C virus. Because of encouraging results of its autophagy inhibitors drug candidates